Form 4 for SNOA Sonoma Pharmaceuticals, Inc.
Accepted 2023-07-03 00:00:00 ET · period of report 2023-06-30 · accession 0001683168-23-004631 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-03 | 2023-06-30 | SNOA | Thornton Bruce | EVP | A - Grant | — | +100.0K | 216.8K | +86% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.0001 par value | 2023-06-30 | A | A | 100,000 | — | 216,781 | D | — | — | (F1) The shares of common stock were awarded and granted to Mr. Thornton for services performed as part of the Company's annual bonus compensation to executives. |